Authorization

Here's what to expect from ERYTECH PHARMA (spons ADRs)'s earnings

ERYTECH PHARMA (spons ADRs) is reporting earnings from Q2 on September 21.



Wall Street analysts are expecting losses per share ofA $0.659.



Go here to follow ERYTECH PHARMA (spons ADRs) stock price in real-time on Markets Insider.

On September 21, ERYTECH PHARMA (spons ADRs) will release figures for Q2.In terms of EPS, 1 analyst is predicting losses of $0.659 per share as opposed to losses of $1.080 per share in the same quarter of the previous year.Wall Street is expecting $1.1 million, an decrease of 53.09% over the prior year quarter.Overall, analysts expect an average loss of $2.740 per share for the current fiscal year, compared to $-3.896 per share in the previous year. On average, analysts predict that the company will report annual sales of $4.5 million.This story was written by Markets Insider's RoboEddy, which automatically writes these stories based on data provided by our partners.
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Январь 2021    »
ПнВтСрЧтПтСбВс
 123
45678910
11121314151617
18192021222324
25262728293031